# EDGAR Filing Document

**Accession Number:** 0001690947
**File Stem:** 0001157523-23-000135
**Filing Date:** 2023-2
**Character Count:** 4944
**Document Hash:** adf046d6dbedb07b6e2a3bf492767663
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001157523-23-000135.hdr.sgml**: 20230201

**ACCESSION NUMBER**: 0001157523-23-000135

**CONFORMED SUBMISSION TYPE**: 6-K

**PUBLIC DOCUMENT COUNT**: 2

**CONFORMED PERIOD OF REPORT**: 20230131

**FILED AS OF DATE**: 20230201

**DATE AS OF CHANGE**: 20230131

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** HEXO Corp.
- **CENTRAL INDEX KEY:** 0001690947
- **STANDARD INDUSTRIAL CLASSIFICATION:** MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833]
- **IRS NUMBER:** 000000000
- **STATE OF INCORPORATION:** A8
- **FISCAL YEAR END:** 0731

**FILING VALUES:**
- **FORM TYPE:** 6-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-38781
- **FILM NUMBER:** 23574171

**BUSINESS ADDRESS:**
- **STREET 1:** 120 CHEMIN DE LA RIVE
- **CITY:** GATINEAU
- **STATE:** A8
- **ZIP:** J8M 1V2
- **BUSINESS PHONE:** 1-844-406-1852

**MAIL ADDRESS:**
- **STREET 1:** 120 CHEMIN DE LA RIVE
- **CITY:** GATINEAU
- **STATE:** A8
- **ZIP:** J8M 1V2

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Hydropothecary Corp
- **DATE OF NAME CHANGE:** 20161128

#### UNITED STATES<br> SECURITIES AND EXCHANGE COMMISSION <br> Washington, D.C. 20549
&nbsp;&nbsp;&nbsp;&nbsp;<br>

### FORM 6-K
&nbsp;&nbsp;&nbsp;&nbsp;<br>

#### REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE<br> SECURITIES EXCHANGE ACT OF 1934

#### For the month of January 2023<br>
&nbsp;&nbsp;&nbsp;&nbsp;<br>

Commission File Number: **001-38781**

**HEXO Corp.**<br> (Translation of registrant's name into English)<br>

**120 chemin de la Rive**<br> **Gatineau, Québec, Canada J8M 1V2**<br> (Address of principal executive office)<br>

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.<br> Form 20-F [ ] Form 40-F [ X ]<br>

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ☐<br>

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ☐

------

---

| | |
|:---|:---|
| **<u>Exhibit</u>** | **<u>Description</u>** |
| [99.1](a53294988ex991.htm) | [Press release dated January, 31, 2023](a53294988ex991.htm)<br>|

---

------

#### SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

---

| | |
|:---|:---|
|  | **HEXO Corp.** |
| Date: January, 31, 2023  | /s/ *Julius Ivancsits* |
|  | Chief Financial Officer |

---

## Exhibit 99.1

**Exhibit 99.1**<br>

**** 

<br> # **HEXO Announces Election of Directors** 
GATINEAU, Québec--(BUSINESS WIRE)--January 31, 2023--HEXO Corp. (TSX: HEXO; NASDAQ: HEXO) ("HEXO"), a leading producer of high-quality cannabis products, today announced that at the annual general meeting of shareholders held on January 31, 2023 (the "Meeting"), each of the eight director nominees was elected as a director of HEXO. Detailed results of the vote are set out below.

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Nominee**  | **Votes For**  | **Votes <br> Withheld**  | **Total Votes <br> Cast**  | **Percentage <br> of Votes For**  | **Percentage of <br> Votes Withheld**  |
| Mark Attanasio  | 2063211  | 434874  | 2498058  | 82.592%  | 17.408%  |
| Vincent Chiara  | 1983425  | 514662  | 2498087  | 79.398%  | 20.602%  |
| Denise Faltischek  | 2072889  | 425198  | 2498087  | 82.979%  | 17.021%  |
| Hélène F. Fortin  | 2076677  | 421412  | 2498089  | 83.131%  | 16.869%  |
| Rob Godfrey  | 2081356  | 416731  | 2498087  | 83.318%  | 16.682%  |
| Peter James Montour  | 1978864  | 519224  | 2498088  | 79.215%  | 20.785%  |
| William Todd Montour  | 1987894  | 510194  | 2498088  | 79.577%  | 20.423%  |
| Roger Savell  | 2068997  | 429091  | 2498088  | 82.823%  | 17.177%  |

---

Shareholders also approved the appointment of Macias Gini & O'Connell LLP as HEXO's auditor for the financial year ending July 31, 2023 and authorized the directors of HEXO to fix the remuneration of Macias Gini & O'Connell LLP.

Further details on all matters brought before the Meeting can be found in the report of voting results and management information circular (as amended) which are available under HEXO's profile on SEDAR.

 **About HEXO Corp.** <br> HEXO is an award-winning licensed producer of innovative products for the global cannabis market. HEXO serves the Canadian recreational market with a brand portfolio including HEXO, Redecan, UP Cannabis, Original Stash, 48North, Trail Mix, Bake Sale and Latitude brands, and the medical market in Canada. HEXO is a leading cannabis products company in Canada by recreational market share. For more information, please visit hexocorp.com.

## Contacts
 **For HEXO media or investor inquiries:** <br> Hayley Suchanek, Kaiser & Partners <br> Hayley.suchanek@kaiserpartners.com